These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20207716)

  • 1. Generation of anti-NAG-2 mAb from patients' memory B cells: implications for a novel therapeutic strategy in systemic sclerosis.
    Traggiai E; Lunardi C; Bason C; Dolcino M; Tinazzi E; Corrocher R; Puccetti A
    Int Immunol; 2010 May; 22(5):367-74. PubMed ID: 20207716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach.
    Lunardi C; Dolcino M; Peterlana D; Bason C; Navone R; Tamassia N; Beri R; Corrocher R; Puccetti A
    PLoS Med; 2006 Jan; 3(1):e2. PubMed ID: 16318412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.
    Lunardi C; Bason C; Navone R; Millo E; Damonte G; Corrocher R; Puccetti A
    Nat Med; 2000 Oct; 6(10):1183-6. PubMed ID: 11017152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAG-2, a novel transmembrane-4 superfamily (TM4SF) protein that complexes with integrins and other TM4SF proteins.
    Tachibana I; Bodorova J; Berditchevski F; Zutter MM; Hemler ME
    J Biol Chem; 1997 Nov; 272(46):29181-9. PubMed ID: 9360996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4.
    Fineschi S; Goffin L; Rezzonico R; Cozzi F; Dayer JM; Meroni PL; Chizzolini C
    Arthritis Rheum; 2008 Dec; 58(12):3913-23. PubMed ID: 19035500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
    Hasegawa M; Takehara K
    Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies.
    Ahmed SS; Tan FK; Arnett FC; Jin L; Geng YJ
    Arthritis Rheum; 2006 Jul; 54(7):2250-62. PubMed ID: 16802364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX
    Luong VH; Utsunomiya A; Chino T; Doanh LH; Matsushita T; Obara T; Kuboi Y; Ishii N; Machinaga A; Ogasawara H; Ikeda W; Kawano T; Imai T; Oyama N; Hasegawa M
    Arthritis Rheumatol; 2019 Nov; 71(11):1923-1934. PubMed ID: 31173491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general approach to the generation of monoclonal antibodies against members of the tetraspanin superfamily using recombinant GST fusion proteins.
    Azorsa DO; Moog S; Cazenave JP; Lanza F
    J Immunol Methods; 1999 Oct; 229(1-2):35-48. PubMed ID: 10556689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P; Fulminis A; Pingiotti E; Marrelli A; Liakouli V; Perricone R; Pignone A; Matucci-Cerinic M; Giacomelli R
    J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocytes: shedding new light on the pathogenesis of systemic sclerosis.
    Hasegawa M
    J Dermatol; 2010 Jan; 37(1):3-10. PubMed ID: 20175836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab.
    Fraticelli P; De Vita S; Franzolini N; Svegliati S; Scott CA; Tonnini C; Spadoni T; Gabrielli B; Pomponio G; Moroncini G; Gabrielli A
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S160-7. PubMed ID: 26339895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.